Stephen R. Marder, M.D.

Biography

Stephen R. Marder, M.D., is the Daniel X. Freedman Professor of Psychiatry, the Vice-Chair for Education, and the Director of the Section on Psychosis at the Semel Institute for Neuroscience and Human Behavior, all at the University of California Los Angeles (UCLA). He is also the Director of the VISN 22 Mental Illness Research, Education, Clinical Center (MIRECC) at UCLA for the Department of Veterans Affairs (VA).

Dr. Marder’s research has focused on improving the lives of individuals with psychotic disorders, particularly schizophrenia. His research has been supported by VA, the Brain and Behavior Research Foundation, and the National Institute of Mental Health, and has focused on the development of pharmacological, psychosocial, and rehabilitation approaches for improving functioning and quality of life. He led the National Institute for Mental Health (NIMH) MATRICS (Management and Treatment Research to Improve Cognition in Schizophrenia) initiative which provided guidance for the development of pharmacological agents to improve cognition and motivation in schizophrenia. He also led an NIMH network for trials of medications for improving cognition in schizophrenia.

From 2016 to 2018 he was the President of the International Society of CNS Clinical Trials and Methodology. He is considered an expert on clinical trials methods for complex CNS disorders, particularly schizophrenia. Dr. Marder has received the Exemplary Psychiatrist Award from the National Alliance for the Mentally Ill, the Stanley Dean Research Award of the American College of Psychiatry, the Alexander Gralnick Award from the American Psychiatric Association, the Kempf Award from the American Psychiatric Association, the American Psychiatric Association Award for Research, the Wayne Fenton Award for Outstanding Clinical Care from the Schizophrenia Bulletin, and the Lieber Prize for Schizophrenia Research.